Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium glubionate anhydrous
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
Calcium glubionate anhydrous is a mineral supplement used to prevent or treat low blood calcium levels in individuals who do not get enough calcium from their diets. It is indicated for the treatment of hypocalcemia, hyperkalemia, lead poisoning, and as an adjunct in the management of exudative skin conditions. The drug acts by providing bioavailable calcium ions that are essential for various physiological processes including bone formation, muscle contraction, nerve function, and blood clotting. Calcium glubionate is classified as a small molecule pharmaceutical and is approved for clinical use[1][2][3].
- Other names
- calcium glubionateglubionate calcium
Beyond the preview
Go deeper on Calcium glubionate anhydrous.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcium glubionate anhydrous.